Wishbone News &
Updates
Biological performance of a novel bovine hydroxyapatite in a guided bone regeneration model: A preclinical study in a mandibular defect in dogs
WHA and BO resulted in similar at 12 and 26 weeks, with higher regenerative performance when compared to the sham controls. However, at 4 weeks, the defect regeneration was significantly enhanced by WHA compared to all other treatments.
ICOI, World Congress, Dallas.
W-Bone will exhibit at the ICOI September 28th - 30th, 2023, in Dallas, TX.
AAID November 2023
The AAID flagship event for implant dentistry is coming to Las Vegas - November 2023.
W-Bone demonstrates improved bone regeneration efficiency - A comparative clinical study.
“This is a very promising result for the use of our innovative graft W-Bone and its highly effective use in dental bone growth and implantation procedures.”
Getting ready for the US market
Wishbone Xenograft receives clearance from the FDA
"We are now reaching the point where the product we have been working on for several years enters the commercialization phase. This is a very exciting time."
Why bone grafts of bovine origin are even better than other types of grafts
Yes, we use bovine femurs, and it is secure: why bone grafts of bovine origin are even better than other types of grafts.